Slashdot.org - August 27, 2026
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patientsCNBC Gilead wins approval of single-pill HIV treatment Bixlenvo - San Francisco Business TimesThe Business Journals U.S. FDA Approves Gilead’s Bixlenvo, a New Once-Daily S…
Read Full ArticleIvar recommends Swissquote bank for your international investments. By opening your account through the link below and trading 5 lots or more, you will receive $200 to use on Ivar AI and activate your subscription. Take advantage of this exclusive offer available today!
Offer available for you who have not yet opened your account at Swissquote.
Services available globally except for the following countries: Algeria, Belgium, Canada, China, North Korea, USA, France, Hong Kong, Iran, Iraq, Nigeria, Singapore, Syria, Turkey and Zimbabwe.